Good practice guidance: supporting people with substance problems at the end of life. by Galvani, Sarah et al.
Galvani, Sarah and Wright, Sam and Witham, Gary (2019)Good practice
guidance: supporting people with substance problems at the end of life. Doc-
umentation. Metropolis, Manchester Metropolitan University.
Downloaded from: http://e-space.mmu.ac.uk/623172/
Version: Published Version
Publisher: Metropolis, Manchester Metropolitan University
Please cite the published version
https://e-space.mmu.ac.uk
1Supporting people with 
substance problems at 
the end of life
Good Practice Guidance
March 2019
Professor Sarah Galvani
Dr Sam Wright
Dr Gary Witham
2Acknowledgements
We are particularly grateful to our external advisors and experts for their 
comments and suggestions on the content of this pocket guide: 
Vicky Lindsay, Aquarius
Dr Laura Chapman, Marie Curie Hospice
Dr Sarah Fradsham, Marie Curie Hospice
Jane Simons, Addaction
Dr Joanna Roberts, Woodlands Hospice. 
We are very grateful to the National Lottery Community Fund for funding 
this guidance and to Manchester Metropolitan’s Policy Unit, Metropolis,  
for supporting the design, production and dissemination of this guide.
Contents
Acknowledgements 2
Introduction 4
Key messages 5
1. Philosophy of care and service approach 6
2. Joint working 8
3.  Talking about substance use and end of life care 10
 Questions to ask about substance use 11
 Questions to ask about needs and wishes for end of life care 12
 Substance use screening and assessment tools 12
4. Pain and symptom management and prescribing 14
 Assessment considerations 14
 Prescribing practice 15
 Monitoring 16
5. Support for staff 17
6. Family, friends and care givers 19
Resources 21
 Tools and information 21
 Useful reports and articles 22
References 23
3
Introduction
This good practice guidance draws from a range of sources 
including international research evidence, the experiences of 
people who use(d) substances who are at the end of their lives, 
and the family members, friends and carers of those people. It also 
draws on professionals’ experiences including paid and volunteer 
professionals who work with people in a range of settings including 
hospices, community health and social care services, substance 
use services, as well as specialists leading work in this area within 
their own disciplines, for example, general practice medicine, 
hepatology, social work.
To our knowledge, it is the first guide of its kind in this newly 
developing field. Work has been developed by St Mungo’s, Marie 
Curie and the Care Quality Commission (CQC) to examine the 
end of life care needs of other disadvantaged groups of people, 
for example, people who are homeless, people from BAME 
communities and LGBTQ+ groups. However, this is the only work 
to explore substance use directly and to consider the impacts that 
problematic substance use (past and present) has upon people’s 
lives and those of their families, friends and carers. This guide 
attempts to bring perceived good practice to individuals living and 
dying with problematic substance use and to the professionals and 
families who support them. It is not exhaustive but offers some 
suggestions and areas for practice development and reflection.
The goal of palliative and end of life care is to give the person the 
best quality of life possible towards the end of their life, and to 
give them, and their family and friends, the best possible care 
experience of dying and death. The World Health Organization 
(WHO) defines palliative care as ‘an approach that improves the 
quality of life of patients and their families facing the problems 
associated with life-threatening illness, through the prevention and 
relief of suffering by means of early identification and impeccable 
assessment and treatment of pain and other problems, physical, 
psychosocial, and spiritual’. 
However, the problem for many people who use(d) substances and 
those caring for them is that their end of life is often only identified 
in the last few weeks or days of life. This means that, for both 
health and social care staff and family/friends, care planning and 
opportunities to talk meaningfully with the person approaching 
death may be extremely limited. Such conversations can be all the 
more difficult for families if relationships have become strained or 
fractured – which is where practitioners working within substance 
use services may be able to help.
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5Figure 1: Complexity of needs
Key messages 
One of the key messages from practice with 
people at the end of their lives with current 
or historic problematic substance use is the 
complexity and multiplicity of their needs (see 
figure 1). This negatively impacts upon their 
engagement with services and the delivery of 
care. It is therefore important to identify these 
needs early and to have local partnerships and 
joint working arrangements in place to ensure 
these needs can be met. No single agency can be 
expected to meet them all.
To meet such needs better training and 
education on substance use and end of life 
care for applied professionals is required as 
well as policy and practice guidance and post 
qualifying training to support those already in 
the workforce. This training should extend to 
social care and other support workers (such as 
staff in shelters), who may not be automatically 
considered, but are working in services where 
they are likely to be in contact with people with 
problematic substance use. The research suggests 
that emotional support for staff is important 
given that working with problematic substance 
use and/or end of life care can be emotionally 
labour intensive.
Other key messages include the need to review, 
or plan for, family service provision. More 
generally, obstacles to accessing specialist 
palliative and end of life care services inhibit the 
delivery of support to a more diverse population. 
For some populations, consideration has to be 
given to delivering end of life care in a range of 
accommodation types. 
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People with problematic substance use (PSU) meet 
hostility, suspicion and frustration from a range of 
care professionals on a regular basis. It prevents 
service access and can lead to mutual suspicion and 
mistrust. Professionals need to counter stigma and 
stereotyping around people with PSU to regain this 
trust. A non-judgemental and empathetic approach 
is needed when working with people with PSU in 
palliative or end of life care, as is a commitment to 
providing the best care and treatment no matter 
what got them there. 
Professionals advise that it can be 
helpful to:
1.  Understand that PSU during palliative care (PC) 
or end of life care (EoLC) is possibly a coping 
mechanism at a difficult time in someone’s 
life. More generally, PSU is a known coping 
strategy for people countering pain, trauma 
and distress.
2.  Understand from the outset that there are 
likely to be unpredictable illness trajectories. 
PSU may also fluctuate – complicating 
identification of symptoms and how and when 
to respond.
3.  Pre-plan care and consider how to manage the 
complexity in order to enable the provision of 
the best possible care – and ensure that any 
anxieties among staff are acknowledged and 
discussed.
4.  Recognise that survival timescales may be 
much shorter and less predictable for people 
with PSU than for many other life-shortening 
conditions – so communication and planning 
may need to be very focused.
5.  Avoid treating people with PSU as if they 
are undeserving – consider their PSU, and 
its consequences, as part of their medical 
condition or social needs. 
6.  People with PSU may not feel deserving of PC 
and EoLC. This needs to be countered with 
compassionate and joined up care. They may 
seem to be defensive and deny that they need 
help – and whilst it is important to respond 
to an individual’s wishes, it may be more 
appropriate to explore with them what their 
previous experiences and current expectations 
of services are and how their engagement with 
services could best benefit them and their 
family or carers.
7.  Harm reduction discussions around PSU are 
more appropriate than ‘recovery’ focussed 
interventions for this group of people. The aim 
is to keep people stable rather than pushing 
for other goals such as abstinence – unless the 
person wants to.
8.  Consider whether waiting list times within 
substance use agencies can be speeded up 
if someone is in need of PC or EoLC. They 
may wish to spend their final days or weeks 
substance free to reengage with family, friends 
and carers.
Service models for people with PSU 
and in need of PC/EoLC 
•  People with PSU and professionals supporting 
them, talk highly of holistic models of care 
where more time can be spent with people. For 
example: alcohol teams that work with people 
on every aspect of their needs, not just the 
alcohol, accompanying them to appointments 
where possible. Hospice care is usually multi-
faceted and geared towards supporting the 
person as they approach the end of their life.
•  Ideally, a coordinated care model is needed, 
with a case manager or care worker to avoid 
people slipping through the gaps. 
•  Involving people with lived experience 
to participate meaningfully in designing, 
assessing, and evaluating services is important.
1. Philosophy of care and  
service approach. 
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7•  At a minimum, close partnership working with 
other appropriate agencies is needed to support 
the individual and their family member.
•  Other options include dedicated specialist 
roles, services, and champions, funded from 
integrated or specialist commissioning, e.g. 
palliative care coordinator for homeless people, 
funding hospice beds in hostels.
•  Assertive outreach and engagement with, for 
example, people who have dropped out of care 
or people needing home visits.
Services need to be:
1.  As flexible and as accessible as possible, 
particularly around appointments.
2.  Aiming for low threshold strategies to care,  
i.e. minimum restrictions on normal patterns  
of behaviour. 
3.  Delivering care in settings familiar to 
individuals, e.g. hostel-based care, home care, 
where possible.
4.  Person-centred – building positive 
relationships, communicating well, providing 
personal care.
5.  Developing safety plans for people whose PSU 
is identified as high risk who have palliative/ 
EoLC needs.
6.  Developing organisational level policies that 
reflect an awareness of the overlap between 
PSU and PC and EoLC. One example would 
be substance use services including a regular 
self-audit of people attending the service using 
a tool such as SPICT or the Surprise Question 
(see resources section). Similarly, PC and EoLC 
services can review the case notes of people in 
their services for any indication of substance 
use and use the AUDIT questionnaire if they 
have concerns.
7.  Providing and encouraging staff to participate 
in workforce development on SU or PC/EoLC.
8.  Clear that managers must offer active support 
to staff to ensure their continued well-being 
while working with these more complex issues. 
This support must not be cut as services are 
squeezed financially. It may include allocating 
staff more time to work with people with 
PC/EoLC/PSU needs, particularly given the 
need for multi-disciplinary and multi-agency 
involvement. 
1. Philosophy of care and  
service approach. 
82. Joint working
Without fail, a clear message for supporting this 
group of people was the need for joint working. 
Research shows that a number of strategies have 
been tried, or recommended, to effect such 
partnerships.
Strategies to effect joint working
1. Building closer working relationships with 
GPs who are a main contact for prescription 
management.
2. Building good relationships with other specialist 
services – even just one lead from each service 
can keep communication channels open.
3. Bringing experts in to team meetings to 
discuss particular issues around PC/EoLC 
and PSU, especially experts in asking about 
‘sensitive’ issues.
4. Establishing working relationships with other 
community agencies, e.g. pharmacists and 
district nurses, to support people in the 
community or if there are concerns over drug 
diversion at home. 
5. Offering training or guidance to other agencies 
– that is, not waiting for them to ask! This 
is particularly important in order to provide 
specialist advice, emotional and practical 
support, and clinical supervision to practitioners 
to counter the emotional demands of working 
with people who are dying.
Practice examples
•  Pallaborative, a PC/EoLC network set up 
in Liverpool, develops local level guidance 
on specific issues of concern across the 
sector regionally. This has recently included 
substance use.
•  A multi-disciplinary network in Liverpool has 
been set up between relevant colleagues from 
across substance use, PC, EoLC, GP, City Council 
and other relevant agencies, to focus on a 
collective response to PC and EoLC for people 
with PSU.
•  A palliative care consultant visited a hospital 
to speak to medical staff about the higher 
doses of medication required for patients with 
histories of, and tolerance to, opiates.
•  Moving a person from the use of Novel 
Psychoactive Substances (NPS) to a pain patch 
to moderate their pain, titrating the transition 
from one to the other with short term, fast 
acting opioids.
•  Joint working between hospital and substance 
use services re prescribing medication to 
people with PSU.
•  Taking specialist consultants to home visits 
to talk to district nurses about whether 
different doses of pain relief are warranted and 
appropriate. Each case needs to be assessed 
on an individual basis, but some people with 
PSU may have a higher tolerance for opioids 
and prescribers will need to consider this when 
dosing analgesics. 
•  Working with homelessness professionals, 
hostels and substance use services to maximise 
the support they can offer and to try to keep 
people safer than on the street.
•  Good GP prescribing of methadone at 
appropriate dose levels – need to work to 
develop relationships with individual GPs and 
consultants.
Professionals advise:
1.  Get consent to share information to avoid the 
person having to repeat the same information 
frequently.
2.  Share information on a person’s care needs 
with GPs, and be prepared to advocate for 
them, particularly around palliative care 
registration. GP’s use of the PC register is 
inconsistent and people with problematic 
substance use may not be considered 
adequately for inclusion.
93.  Share information and be prepared to 
advocate for people with other services and 
professionals too – arrange for support to 
appointments where possible to offer support 
and advocacy. Vital to this process is the need 
to communicate well to understand what each 
service is doing and to understand the role and 
remit of the other professionals involved in 
someone’s care.
4.  It is important to see interventions for  
PSU and palliation in tandem: it is not an  
‘either/or’ choice.
5.  Acute or social care professionals could 
consider whether referrals are needed to both 
addictions team and PC/EoLC services.
6.  Work together on what advance care planning 
might look like for someone at end of life with 
problematic substance use.
7.  Discuss with practice partners who is taking 
responsibility for the oversight of the person’s 
care otherwise the person might fall between 
the gaps in services. Don’t allow this discussion 
to become an obstacle to appropriate and 
empathic care. 
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“We’re already happy to talk about death 
and dying and your plans and how you 
might die...we can talk about that all 
day long and not be upset about raising 
those questions with patients, but yet I’d 
probably have palpitations ...asking, ‘Have 
you been injecting heroin again or what 
have you been drinking?’ 
(Group 2 – Senior HSCP)  
(Templeton et al. 2018: 34)
Social and health care professionals are experts at 
asking people for all sorts of personal information. 
Professionals are confident in the questions they 
ask routinely, but less so when it is something 
they are not familiar with. Evidence suggests that 
people want to know more about what and how 
to ask someone about their substance use or their 
wishes and needs as they approach the end of 
their lives. 
•  Remember, words only make up a small 
proportion of communication – tone of voice, 
facial expressions, eye contact and other non-
verbal communication are important 
•  Direct questions can be asked sensitively. 
Remember, too, that there may be literacy 
problems so paper-based or self-completion 
forms may not be appropriate.
•  It is also important to understand that 
problematic substance use fluctuates along 
with the impact of it so what might feel (or be) 
life threatening one week may not appear, or 
be, so the week after.
•  The more information you have on the 
different roles of people in PC/EoLC and 
substance use services the easier it will be to 
seek support and advice – and the easier it will 
be to explain to people approaching the end 
of their life about how they may benefit from a 
referral.
•  People with PSU will normally have a range 
of needs, including poor mental health 
and possible cognitive impairment. Talking 
to colleagues in mental health services 
about how to identify and assess mental 
health needs and cognitive impairment at a 
preliminary or ‘triage’ level is advisable.
Definitions
• Establish what is meant by palliative, end of 
life, and problematic substance use within your 
agency. However, when working with others, 
clarify what their definitions are so you’re not 
talking at cross purposes. Definitions can vary 
hugely between agencies and the public can 
have a different perception too. 
• Avoid a narrow interpretation of end of 
life: the Prognostic Indicator Guide (PIG) 
is a good place to start – https://www.
goldstandardsframework.org.uk/cd-
content/uploads/files/General%20Files/ 
Prognostic%20Indicator%20Guidance%20
October%202011.pdf 
• The language of substance use can be 
complicated. Use of the terms ‘misuse’, ‘abuse’, 
‘dependency’, are used interchangeably and 
sometimes mean any use, problematic or not! 
‘Substance’ is often taken to mean illicit drugs 
rather than any substance including alcohol. 
• The use of different terms also come from 
different perspectives and views on the nature 
of substance use or problematic substance 
use. People with PSU may feel very stigmatised 
and defensive, avoid using terminology or 
assumptions about them that risk exacerbating 
any shame they may feel.
3. Talking about substance use and  
end of life care
Examples:
• Can you tell me about your alcohol 
and other drug use right now and 
how that is helping you at this time?
• What would you like to do in 
relation to your substance use and 
how can we help?
• We will not judge you for your 
substance use, we just need to 
make sure we can give you the right 
medications and care – we don’t 
want to make things worse for you.
• I am not suggesting you stop using 
or drinking if that’s what you want 
to do, but knowing a little about 
what you are using will help us to 
keep you safe medically.
• To what extent would you like 
to change anything about your 
drinking/using at this time?
• Is there anyone around you we 
should know about that can support 
you in making the changes you want 
to make to your substance use? 
What has helped you previously?
• Are there people we should know 
about who you might want to avoid, 
to help you make the changes you 
want to make in relation to your 
substance use? 
• Start by differentiating between any use of 
substances (including alcohol and prescribed 
drugs), and the problematic use of substances 
in terms of considering responses and 
interventions.
• Sometimes clear definitions and prognoses are 
hard. Understand that a number of life limiting 
conditions are unpredictable.
Questions to ask about 
substance use
Finding the best approach to asking questions 
about substance use starts with clarity about 
why you’re asking and what your value base 
is. The following quote comes from a hospice 
professional who is not judging the person for 
their alcohol problems in the final period of 
their life but is also wanting to offer the person 
a choice and support around their drinking if 
they want it:
“Let them know that we do not want 
to take you away from this situation 
at this moment in time, we don’t 
want you to stop drinking, we don’t 
want you to stop living your life how 
you have always lived it. What we 
want to do is support you.” 
(Group 1 – Frontline HSCP) 
(Templeton et al. 2018: 39/40)
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Questions to ask about 
people’s needs and 
wishes for end of life care
Some people will not want to stop their substance 
use. However, they still need to be offered advice 
and choices, where available, about their options 
for palliative and end of life care. One frontline 
professional found that, in such circumstances, 
it was helpful to set aside discussion about the 
substance use and proceed with discussion about 
palliative and end of life care. 
“Right, let’s assume that you’re not going 
to stop drinking, then let’s look at that and 
then I can refer you to the hospice, I can 
refer you to a counsellor, I can refer you to 
other things’, like you and I would access 
(Group 1 – Frontline HSCP)“ 
(Templeton et al. 2018: 39/40)
• You need to be able to talk about death with 
someone particularly if you’re already talking to 
them about long-term conditions and multiple 
medical needs. People may drop cues into 
conversation to see if you will pick up on them 
as they may not know how to raise the topic. 
It is important not to miss those opportunities 
and to listen carefully for cues.
• It can be difficult to use the terms ‘end of life’ 
with people. Sometimes asking open questions 
can help the patient to then direct the 
conversation:
• How do you feel things have been with your 
health recently? Have you had any concerns 
about this? Questions about the future can 
also be helpful.
• Not everyone will want to talk about their 
death or dying so make a professional 
judgement based on initial sensitive enquiries 
about end of life care. For some people, it 
might be a question of picking the right time. 
It might be appropriate to gently introduce 
the idea after a ‘close call’ with serious illness/
death. Perhaps frame it in terms of:
•  Your recent illness made me realise that 
we should have a conversation about what 
your wishes are if you become ill like that 
again. Who would you want me to contact? 
Where do you want to be cared for? What 
do we need to think about to plan for your 
future care?
• Alternatively: Perhaps if we write your next 
recovery plan to include some things that 
will help you stay well and do the things that 
are important to you , but also put in some 
mention of what you would want if you 
become very poorly again... .
• Reassure people with PSU that their end of life 
will be made as comfortable as possible and 
prescribing will take account of their other drug 
use.
• The Serious Illness Care Programme is being 
piloted in the UK with guidance on how to have 
conversations about serious illness – initially 
it is targeted at “doctor and patient”. Progress 
and future resources can be followed online at: 
http://betterconversations.org.uk/about/ 
Further examples:
• What do you want your end of life to look like? 
Is there anything that you’d like to change? 
• How can we improve your end of life 
experience? How can we make it what you 
want it to be?
• Would you like to be supported to continue 
drinking or using when you are at the end  
of life?
• What are your fears or concerns about your 
substance use towards the end of life?
Substance use screening 
and assessment tools
There is limited evidence of the efficacy of 
substance use screening tools within a palliative or 
end of life care population. However, the evidence 
suggests that screening and ongoing assessment is 
important as people’s use may change and this will 
need considering in relation to their care planning. 
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As a starting point, something more conversational 
as suggested above is likely to be less intimidating 
than a formal assessment tool, particularly for 
people at or near the end of their lives. Above 
all, the most important consideration is how any 
screening tool is used – it needs to be introduced 
in a way that ensures the individual being 
screened feels compassionate understanding.
The following tools can be used but it is also worth 
contacting your local alcohol and drug services 
and asking them to suggest screening questions 
for you.
Universal screening tools for  
alcohol use
• The UK Government website provides a link 
to a number of alcohol screening tools and 
can be accessed online here: https://www.
gov.uk/government/publications/alcohol-
use-screening-tests. This includes the AUDIT, 
commonly considered one of the best alcohol 
assessment tools available and validated with 
different groups of people with different co-
existing needs.
• There are also a number of screening tools 
used with older people including The MAST- G 
(Michigan Alcohol Screening Test – Geriatric) 
is a specific screening tool for assessing 
alcohol use in the elderly. MAST – http://
www.the-alcoholism-guide.org/michigan-
alcohol-screening-test.html There is also a 
short version of the tool (called the SMAST-G) 
which may be useful. http://sbirt.vermont.
gov/screening-forms/older-adult-alcohol-
screening-instrument/ 
• The British Liver Trust provides a range of 
information for practitioners and clients 
about the liver, including where there are liver 
problems because of alcohol use. https://www.
britishlivertrust.org.uk
• The Royal College of Psychiatrists (2015) has 
produced an information guide on Substance 
misuse in older people. https://rcpsych.ac.uk
Universal screening tools for illicit 
drug use
• There are few agreed and validated tools for 
assessing substance use other than alcohol. One 
short screening tool is the DAST – Drug Abuse 
Screening Tool.  http://www.emcdda.europa.eu/
html.cfm/index3618EN.html
• The clinical Opiate Withdrawal Scale (COWS) 
may be useful to measure any withdrawal 
symptoms from opiates – https://www.
drugabuse.gov/sites/default/files/files/
ClinicalOpiateWithdrawalScale.pdf  
• Other tools are available for different groups of 
people or substances of choice. https://smartcjs.
org.uk/professionals/gps/screening-tools/ 
Additional guidance suggests:
• Observe for behaviours associated with 
problematic substance use (requests for dose 
escalation, A&E visits, unscheduled clinic 
visits related to pain complaints, seeking 
early prescriptions, lost opioid prescriptions, 
approaching different prescribers, forged 
prescriptions). 
• There is a need for non-judgemental curiosity 
when such presentations occur – not 
automatically assuming that an individual 
is drug seeking, but exploring whether they 
perhaps have poor coping strategies, are 
feeling scared, or are in pain. 
• Equally you may notice behaviours, such as 
using more drugs than have been prescribed, 
looking for intoxication. Exploring the reasons 
behind behaviour will support teams to provide 
the best care. It can also trigger conversations 
about EoLC and future planning, or, if those 
have already taken place, ensure individuals 
continue with EoL/palliative care. Don’t waste 
opportunities.
• Assess and proactively treat alcohol or drug 
withdrawal at the end of life. 
• Check whether people can actually get to 
appointments – physically and financially.
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“I guess where we hear about things 
that are of concern clinically, [it] will be 
things like people being afraid to prescribe 
analgesia properly, particularly if somebody 
has a heroin or some kind of a drug related 
abuse...my clinical experience is that some 
people, particularly with heroin abuse or 
related drugs, have a very high tolerance 
for the drug and therefore they need really 
big doses...people are really afraid of really 
big doses and so I think that there is a 
tendency to underserve this population.”
(Group 3 – Policy & Commissioning 
Professionals) (Templeton et al. 2018: 51)
The primary challenge identified in the evidence 
for health professionals in particular, was the 
difficulty they faced around appropriate pain and 
symptom management and prescribing practice 
for people with current or historic problematic 
substance use. 
Prescribing pain medication for people with 
problematic substance use at, or near, the end of 
their life is complex but good practice is achievable. 
Much of the existing literature is based on 
anecdotal evidence rather than strong empirical 
data. There is evidence of under prescribing for 
pain because of concerns about overdose and 
professional culpability. Some literature refers to 
‘pseudo-addiction’ where illicit substances are 
sought to supplement under prescribing of pain 
medication. Screening, effective supervision and 
close monitoring of prescribing can overcome most 
of these concerns. 
Assessment 
considerations
• Assessment before and after prescribing 
medication is an important step to manage 
pain effectively. Health professionals need to 
distinguish between active users, individuals 
in methadone replacement therapy, and those 
in recovery. This often needs comprehensive, 
expert negotiations that may require inter-
disciplinary communication with drug, alcohol, 
and psychiatric services.
• Assessment of the attitude and perceptions of 
opioid use from the person with problematic 
substance use at the end of life is also crucial. 
If that person is in recovery they may be 
reluctant to take opioid-based medication. This 
is generated from the fear of the addiction/
withdrawal and the historic problems those 
substances caused in the person’s life. 
• Alternatively, the person may be concerned 
with stigma and believe there would be a 
withdrawal of care and opioid medication if 
they were open and honest about their illicit 
drug or alcohol use.
• Discuss drug use and its impact and the 
importance of being open with health staff so 
that they can ensure pain and other symptoms 
are managed. This should include situations 
where the person reduces or stops their illicit 
drug use or alcohol use.
• Conduct frequent pain assessments and 
reviews of symptom distress. This is likely to be 
required more frequently than ‘normal’.
• Implement safety plans for identified 
patients with substance problems or high risk 
patients. Involve and/or refer to specialist 
Multi-disciplinary Team (MDT) support that 
may include psychiatric/ psychological, or 
drug and alcohol services. This may include 
supervised medicines administration by health 
professionals. 
4. Pain and symptom management 
and prescribing
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• During follow-up visits use tools such as the 
Pain Assessment and Documentation Tool 
(PADT) to assess levels of analgesia, the effect 
on capacity to self-care, and any adverse 
reactions. https://www.quest.scot.nhs.uk/
hc/en-gb/articles/115004244089-Pain-
Assessment-and-Documentation-Tool
• Set realistic goals related to pain management 
at the end of life that are based on harm 
reduction rather than abstinence goals.
• Look out for similar symptoms that can be 
easily misdiagnosed, e.g. sudden withdrawal 
from substances vs peritonitis.
• Assess for withdrawal symptoms resulting from 
physical deterioration and inability to physically 
access substances including illicit drugs, 
tobacco and alcohol – medicate or facilitate use 
(where appropriate).
Prescribing practice
• Reassure people that their pain will be 
managed in the same way that other people’s 
pain is managed. This will help to allay 
fears and avoid minimising or hiding their 
substance use.
• Clear and honest communication is required 
with the person with problematic substance 
misuse to encourage them to disclose the 
type and volume of substances in order to 
help professionals evaluate any potential 
interaction with prescribed medication. This 
pharmacological complexity may require 
specialist pharmacist involvement and would 
need to be underpinned by a person-centred 
approach to patient care.
• Understand people may have a high tolerance 
to opiate based painkillers if they have histories 
of problematic substance use and adapt 
prescribing practice accordingly.
• Clinicians need expertise and confidence to 
manage pain requiring higher opioid titration 
that may exceed standard prescribing protocols 
for end of life care. This relates to other 
symptom management medication that could 
have been misused previously and is, as a 
result, required at a higher dose, for example, 
to treat anxiety. Collaboration and training with 
drug and alcohol services may increase this 
confidence. 
• Levels of prescribing may need to be higher 
because of tolerance from historic drug use – it 
might not be appropriate to prescribe to levels 
advised in clinical guidelines. Every case should 
be assessed on an individual basis because 
although these can be issues, it should not be 
assumed that they are.
• Arrange for supervised consumption of alcohol 
and other drugs in the community as well 
as in care services that take account of the 
(changing) physical capacity of each individual.
• In terms of safety in managing pain at the end 
of life in the presence of substance misuse, 
more frequent outpatient appointments, 
the use of slow release pain medication with 
limited supply of breakthrough opioids (that 
can be monitored) may be beneficial. 
• There may be issues to do with prescribing 
and substance use that need considering. For 
example: being maintained on methadone, 
being placed in a wet hostel, people with opiate 
use histories not wanting to be prescribed 
opioids, or services that have a zero tolerance 
substance use policy. These need to be 
considered as part of the prescribing process 
and follow up.
• Clear inter-disciplinary communication is vital 
to assess the potential risk of poly-prescribing 
and poly-pharmacy, with potentially multiple 
prescribers working with people with substance 
use problems (for example, A & E departments, 
psychiatric or drug and alcohol services).
• If people become physically unable to smoke, 
drink or use drugs independently, they will 
experience the negative impact of withdrawal 
symptoms. Professionals need to be aware of 
this to prescribe additional drugs to maximise 
their comfort during that time. 
• While there is currently no guidance for this 
group of people specifically, NICE guidance 
on prescribing strong opioids in palliative 
care is available at: https://www.nice.org.uk/
guidance/cg140/resources/palliative-care-
for-adults-strong-opioids-for-pain-relief-
pdf-35109564116677  
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Monitoring
• Discuss with the person how, and whether, 
they will be able to keep their prescribed drugs 
safe in the home.
• Some examples of what could be considered 
include the use of safes, lock boxes, daily 
deliveries, or next of kin looking after 
medication.
• Pill counting may be a way to assess for drug 
diversion and the use of non-opioid adjuvant 
medications may be preferable whenever 
possible, in order to maintain safety and 
reduce risk. 
• Don’t assume people have ulterior motives for 
wanting pain medication – discuss concerns 
and plan with the individual and family/friends 
(if appropriate). 
• If it becomes clear at some point that people 
do have ulterior motives for wanting pain 
medication, consider why that might be 
and how you can support them to do things 
differently. It may be a way they have used to 
cope with high stress situations for example. Be 
curious, rather than judgemental, about what 
such behaviour might mean and what insight 
this can offer you in terms of offering support.
• For people with PSU who are homeless, 
it may be a shelter worker or a friend at a 
hostel who is closest to the person and could 
potentially assist with medication dispensing 
and monitoring. But this requires proactive 
engagement and relationship building from 
health and social care staff to facilitate this.
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5. Support for staff
“this is not how they want[ed] their life 
to be, not the script that they wrote for 
themselves, it’s just where they are…’ 
(Substance Use professional) 
(Galvani et al., 2018)
The complex needs of people with PSU needing 
palliative or end of life care can add stress 
and strain on frontline practitioners, however 
experienced they are. They are not immune to the 
sadness and loss when someone they are working 
with dies, nor to the frustration and emotions that 
accompany working with someone who does not 
want to change their problematic substance use. 
Evidence from Galvani et al. (2018) suggests it is 
important to acknowledge and provide emotional 
support for staff as well as training opportunities 
to help them work more confidently with this 
potentially growing group of people and their 
families. What professionals found helpful and 
supportive was:
• Pairing practitioners with volunteers to 
facilitate close working and mutual support.
• Working in pairs of practitioners where 
perceived risks were identified relating to 
substance use, paraphernalia and drug dealing 
environments.
• Having a team approach, rather than an 
individual approach to care. This was very 
helpful in developing care provision and 
supported decision-making – particularly 
MDT. It helped to overcome the fear of getting 
it wrong – a fear for patients and for their 
professional status.
• Having regular supervision (internal and/or 
external) around loss and bereavement for staff.
• Emotionally responsive teams were 
valued, as were managers who balanced 
the administration requirements with 
the emotional support needs of staff, and 
colleagues who supported each other.
• For substance use professionals, a team based 
approach to anticipating death and loss among 
people was helpful. Talking about death and 
loss more regularly with colleagues helped it to 
become a more normal part of their role.
• Understanding what a ‘good death’ would be 
for each person.
• Existing guidance on managing multiple, 
long term conditions could be adapted for 
responding to this group of people (Goodwin 
et al. 2010).
A large number of topics for further training 
were found in the evidence base. There was 
some evidence that professionals lacked 
confidence in asking about the ‘other’ topic 
(either substance use or end of life) and that 
some mileage might be made in reminding them 
that they are already skilled communicators 
in one field of knowledge and that such skills 
are transferable in relation to dealing with 
uncertainty, sensitive issues, family members. 
However, there were some common themes for 
training that crossed both substance use and 
palliative/end of life care professional groups: 
• Pain management for people with PSU
• Working with specialists from the ‘other’ area
• What a care pathway might look like between 
substance use services and Palliative/EoL care
• The need to develop specialist training 
partnerships between hospices and substance 
use agencies
• Having a specialist or lead in EoLC/Substance 
Use on team or easily accessible as a key 
point of contact
Training is important to ensure a consistent 
agency response to the needs of people with 
PSU at or near the end of their lives. Training 
and resource requests are listed below to help 
the development of local training exchanges 
and planning: 
Substance use professionals Palliative and end of life care professionals
• Training pack on working with 
people with life-shortening 
conditions in substance use services
• Identification and asking questions about 
substance use; how to talk about it
• Identification and asking questions 
about physical health conditions and 
diagnoses
• Management of medication where there is 
substance use
• Planning and talking about EoLC
• Staff need for psychological support – additional 
stress of hearing people’s past lives
• How to deal with bereavement  
– avoiding ‘we know how you feel’
• Impact of substance(s) on physical and mental 
health
• Types of palliative and EoLC 
intervention available
• Types of substance use treatment available
• Emotional responses to end of life 
care
• Effective communication training before the 
implementation of screening/assessment tools
• Identifying life shortening illness 
and range of conditions
• Identifying problematic alcohol and drug use
• Impact of EoLC on family and 
supporting families through EoL and 
bereavement
• Impact of PSU on children, families and parenting 
and supporting them through palliative/EoLC
• Assess risk relating to end of life • Drugs and their effects
• Attitudes and values re EoLC
• Ethnicity, culture and EoLC
• Gender differences in EoLC
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Professionals describe how:
• Families of people with substance problems 
can be isolated from sources of support. This 
includes at their relative’s end of life when 
they are in need of support in their own right, 
but may be unable to talk to non-professionals 
about it through fear of stigma, shame, 
embarrassment, self-blame.
• Family members may need specialist 
bereavement support after their relative’s 
death as many feel that they are ‘unentitled’ or 
less deserving of support than other families 
because their dead relative ‘brought it on 
themselves’ or because their relationship had 
been problematic and/or confrontational.
• As a result, they can feel out of place in generic 
bereavement groups, where bereaved family 
members with less conflicted relationships 
with their deceased relatives struggle to 
understand their pain and distress.
• Families may not want substance use recording 
on their relative’s death certificate.
Service models for supporting 
families and carers of people with 
PSU and in need of PC/EoLC 
• Families described good practice by health and 
social care professionals in terms of openly 
empathetic, compassionate and holistic care. 
They felt comfortable talking with a non-
judgemental professional who recognised the 
strain they were under and would respond 
to help ease the situation for them and their 
dying relative.
Key messages for practitioners to 
share with families, friends and 
caregivers:
• Grief is always difficult to come to terms with 
and we can often feel we are facing it alone.
• Due to their substance use, we may have had 
a difficult relationship with our relative while 
they were alive and this will inevitably have 
made caring for them more challenging and 
our bereavement more painful.
• Our relative’s life may have been unhappy or 
painful, and our memories of life with them 
may be distressing. Our relative may have had 
mental health problems and their behaviour 
may have caused huge disruptions within the 
family. We may find it particularly difficult to 
look at photographs and try to remember 
good times. 
• We may feel shame at having had a relative 
who used substances problematically and a 
sense of powerlessness at not having been able 
to change their behaviour. We may feel guilty 
that our own substance use added to their 
difficulties in reducing/controlling their use.
• We may feel guilt that somehow we could or 
should have done things differently to make 
their life more bearable, or even that it was 
perhaps our fault that they used substances 
like they did.
• Some of us will have been estranged from 
our relative at the time of their death and 
may regret not having been able to repair 
relationships, or feel guilt at not caring for 
them more practically. 
• We may have felt abandoned by the 
professional services and know that more 
could have been done to prevent this tragedy 
from happening.
• We may have fears about the impact of our 
own substance use upon our health, or over 
our children perhaps experiencing substance 
use problems and mental health difficulties in 
the future.
6. Family, friends and care givers
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Services need to:
• Assess what family support there is available 
for people in their own right.
• Discuss safe medication management with 
them if appropriate.
• Assess (sensitively) family members’ and 
significant others’ risk of potential drug 
diversion – ensuring that perceptions of ‘risk’ 
are proportionate and not solely informed by 
negative stereotypes of people with substance 
problems.
• Recognise that family members can be viewed 
negatively by some staff and volunteers, 
particularly if they have their own substance 
problems or behave in an uncooperative or 
‘chaotic’ way. Training about the support 
needs of families of people with substance 
problems and how best to address those 
needs may be required.
• Be aware that some families will have 
experienced poor responses from health and 
social care practitioners – either for themselves 
and/or their relative – as a result of the 
substance use label.
• Recognise and respond to the range of roles 
of family, friends and care givers – some may 
be using substances, some may be supportive, 
some may be estranged, they may be 
attempting reconciliation, may be abusive, may 
be angry and grieving, etc.
• Consider providing volunteers to support 
family members during and after death 
of their relative – this can be particularly 
effective where those volunteers have personal 
experience of having had a substance problem 
or of having cared for someone with a 
substance problem.
• Encourage and support people to access 
bereavement support groups or counselling  
– including specialist services, if possible.
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Resources 
End of life care for people with problematic 
substance use
Research Briefings, Full Reports, and other 
resources from Manchester Metropolitan 
University’s research on end of life care for people 
with problematic substance use. Available at: 
https://endoflifecaresubstanceuse.com/
• To be added to the Community of Practice 
network set up at ManMet, please contact Dr 
Sam Wright on sam.wright@mmu.ac.uk 
Tools and information
Adfam 
Adfam is the national organisation working with 
and for families affected by drugs and alcohol. 
https://www.adfam.org.uk 
Al-Anon Family Groups 
This fellowship, based on 12 step models  
of peer support, offer support to families  
affected by a relative’s problem drinking. 
http://www.al-anonuk.org.uk/
Amber Care Bundle 
A communication and planning tool for clinical 
teams to proactively manage the care of hospital 
patients who are facing an uncertain recovery 
and who are at risk of dying despite treatment. 
“Uncertain recovery” is taken to mean that a 
patient is being actively treated for an acute 
problem but may not recover, due to limited 
reversibility caused by an underlying illness. 
https://www.ambercarebundle.org/homepage.
aspx [Accessed 26/03/19]
See also: Guy’s and St Thomas’ NHS Foundation 
Trust 2015 The AMBER care bundle – a guide for 
patients, their relatives and carers. https://www.
ambercarebundle.org/documents/amber-care-
bundle-a-guide-for-patients-their-relatives-and-
carer.pdf [Accessed 26/03/19]
Cruse 
Cruse supports people who have been  
bereaved due to the death of someone close.  
http://www.cruse.org.uk/
DrugFAM 
DrugFAM provides support to families, friends and 
carers who are struggling to cope with a loved 
one’s addiction to drugs or alcohol.  
https://www.drugfam.co.uk/
Dying Matters
Dying Matters aims to help people talk more 
openly about dying, death and bereavement, and 
to make plans for the end of life. Among a range 
of services, it offers Find Me Help which is the 
UK’s most comprehensive directory of services 
for people in the last years of life, their families, 
carers and friends – https://www.dyingmatters.org 
[Accessed 26/03/19]
Macmillan Cancer Support 
Macmillan provides practical, medical and 
financial support and end of life care and pushes 
for better cancer care. http://www.macmillan.org.
uk/information-and-support/coping/at-the-end-
of-life
Marie Curie 
Marie Curie offer a range of resources  
and support through terminal illness.  
https://www.mariecurie.org.uk/
National Council for Palliative Care
NCPC is an umbrella charity for organisations in 
the UK working with people in palliative or end 
of life care. https://www.ncpc.org.uk/ [Accessed 
26/03/19]
Pallaborative network
A collaboration of health care professionals 
working in specialist palliative care, patients and 
members of the public from across the North 
West of England, working to improve the quality 
of care for people with advanced progressive 
disease and to ensure care is based on the best 
and most up to date evidence possible. The 
website contains a range of clinical audit, guideline 
development and education materials, 
useful for all health care professionals who care 
for people with advanced, progressive disease. 
The clinical standards and guidelines for palliative 
and end of life care are developed using a  
robust process and are NICE accredited.  
https://pallaborative.org.uk/
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The Royal College of Anaesthetists (RCoA)
The UK professional body responsible for the 
quality of patient care through the maintenance 
of standards in anaesthesia, critical care and pain 
medicine – provides a lot of useful information 
about opioid use and pain management: 
https://www.rcoa.ac.uk/faculty-of-pain-medicine/
opioids-aware/opioids-and-addiction  
The Serious Illness Care Program study (and 
conversation guide).  
(Ariadne Labs 2016) https //www.ariadnelabs.org/
wp-content/uploads/sites/2/2019/03/SI-DFCI-
Outcomes-fact-sheet-2019-03-12c.pdf [Accessed 
26/03/19]
SMART Recovery Family and Friends Programme 
SMART UK offers group based support to those 
affected by another’s substance use.
https://www.smartrecovery.org.uk/family-friends/ 
The Supportive and Palliative Indicators Care 
Tool (SPICT).
Devised by the University of Edinburgh (Updated) 
(2018) www.spict.org.uk [Accessed 26/03/19]
Useful reports  
and articles
Action on Addiction (2013) The management of 
pain in people with a past or current history of 
addiction. Available online at: https://idhdp.com/
mediaimport/38281/130607_pain_management_
report__final_ embargoed_13_june.pdf [Accessed 
27/03/19]
Baile, W.F., Buckman, R., Lenzi, R., Glober, G., 
Beale, E.A. and Kudelka, A.P. (2000) SPIKES—A Six-
Step Protocol for Delivering Bad News: Application 
to the Patient with Cancer.  The Oncologist. 5, 
4, 302-311. doi: 10.1634/theoncologist.5-4-302 
http://theoncologist.alphamedpress.org/
content/5/4/302.long  [Accessed 26/03/19]
British Pain Society (in collaboration with The 
Royal College of Psychiatrists, The Royal College of 
General Practitioners and The Advisory Council on 
the Misuse of Drugs) (2007) Pain and substance 
misuse; improving the patient experience. 
London, The British Pain Society. https://www.
britishpainsociety.org/static/uploads/resources/
misuse_0307_v13_FINAL.pdf [Accessed 26/03/19]
Care Quality Commission (2016) A different 
ending: addressing inequalities in end of life care. 
Newcastle upon Tyne, CQC. https://www.cqc.org.
uk/sites/default/files/20160505%20CQC_EOLC_
OVERVIEW_FINAL_3.pdf
Clinical Guidelines on Drug Misuse and 
Dependence Update Independent Expert Working 
Group (2017). Drug misuse and dependence: 
UK guidelines on clinical management. London, 
Department of Health https://www.gov.
uk/government/publications/drug-misuse-
and-dependence-uk-guidelines-on-clinical-
management
Goodwin, N., Curry, N., Naylor, C., Ross, S. and 
Duldig, W. (2010) Managing people with long-
term conditions.  London: The King’s Fund. 
https://www.kingsfund.org.uk/sites/files/kf/field/
field_document/managing-people-long-term-
conditions-gp-inquiry-research-paper-mar11.pdf
Kendrick, E. (2013) Getting it Right: Improving End 
of Life Care for People Living with Liver Disease. 
NHS Liver Care http://www.hcvaction.org.uk/
resource/getting-it-right-improving-end-life-care-
people-living-liver-disease  [Accessed 26/03/19]  
See also: Gold SF Prognostic Indicator Guide 
(PIG) https://www.goldstandardsframework.
org.uk/cd-content/uploads/files/General%20
Files/Prognostic%20Indicator%20Guidance%20
October%202011.pdf
Musgrave, C., Timms, A., Georgiou, G., Glover, S., 
Sque, M., Black, D. and Perry, I. (2018) ‘Alcohol-
related harm: developing a drug and alcohol 
liaison team.’ British Journal of Nursing. 27, 15, 
Published Online: 8 Aug 2018. https://www.ncbi.
nlm.nih.gov/pubmed/30089057
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